Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Design Therapeutics, Inc. | 415,000 | reported | 01 Feb 2023 | tx 4+897,450 |
| AVANIR PHARMACEUTICALS | 348,901 | reported | 18 Dec 2014 | tx 23+566,141−147,678 |
| ABEONA THERAPEUTICS INC. | 72,296 | reported | 20 May 2020 | tx 6+570,000 |
| AveXis, Inc. | 0 | reported | 15 May 2018 | tx 7+11,766−11,766 |
1 purchase reported after at least 12 months of silence — most recent on 19 Dec 2022.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Feb 2023 | GRANT_AWARD | Design Therapeutics, Inc. | 415,000 | 0.00 USD | deriv |
| 20 Dec 2022 | PURCHASE | Design Therapeutics, Inc. | 6,300 | 8.38 USD | |
| 19 Dec 2022 | PURCHASE | Design Therapeutics, Inc. | 1,150 | 8.47 USD | first after silence |
| 01 Feb 2022 | GRANT_AWARD | Design Therapeutics, Inc. | 475,000 | 0.00 USD | deriv |
| 20 May 2020 | GRANT_AWARD | ABEONA THERAPEUTICS INC. | 100,000 | 0.00 USD | |
| 20 May 2020 | GRANT_AWARD | ABEONA THERAPEUTICS INC. | 72,296 | 0.00 USD | deriv |
| 16 Mar 2020 | GRANT_AWARD | ABEONA THERAPEUTICS INC. | 127,704 | 0.00 USD | deriv |
| 31 Jan 2019 | GRANT_AWARD | ABEONA THERAPEUTICS INC. | 60,000 | 0.00 USD | deriv |
| 11 Feb 2019 | GRANT_AWARD | ABEONA THERAPEUTICS INC. | 110,000 | 0.00 USD | deriv |
| 09 Apr 2019 | GRANT_AWARD | ABEONA THERAPEUTICS INC. | 100,000 | 0.00 USD | deriv |
| 15 May 2018 | OTHER | AveXis, Inc. | 1,106 | 0.00 USD | |
| 15 May 2018 | OTHER | AveXis, Inc. | 7,755 | 0.00 USD | deriv |
| 15 May 2018 | OTHER | AveXis, Inc. | 2,905 | 0.00 USD | deriv |
| 13 Mar 2018 | GRANT_AWARD | AveXis, Inc. | 1,106 | 0.00 USD | |
| 13 Mar 2018 | GRANT_AWARD | AveXis, Inc. | 2,905 | 0.00 USD | deriv |
| 30 May 2017 | GRANT_AWARD | AveXis, Inc. | 5,301 | 0.00 USD | deriv |
| 30 May 2017 | GRANT_AWARD | AveXis, Inc. | 2,454 | 0.00 USD | deriv |
| 18 Dec 2014 | EXERCISE | AVANIR PHARMACEUTICALS | 32,291 | 2.59 USD | |
| 18 Dec 2014 | SALE | AVANIR PHARMACEUTICALS | 15,505 | 16.93 USD | |
| 18 Dec 2014 | TAX_WITHHOLDING | AVANIR PHARMACEUTICALS | 19,204 | 16.99 USD | |
| 18 Dec 2014 | EXERCISE | AVANIR PHARMACEUTICALS | 32,291 | 0.00 USD | deriv |
| 10 Nov 2014 | GRANT_AWARD | AVANIR PHARMACEUTICALS | 59,231 | — | |
| 10 Nov 2014 | GRANT_AWARD | AVANIR PHARMACEUTICALS | 34,825 | — | |
| 24 Oct 2014 | SALE | AVANIR PHARMACEUTICALS | 8,426 | 11.80 USD | |
| 28 May 2014 | SALE | AVANIR PHARMACEUTICALS | 13,547 | 5.18 USD |